The data obtained in these mice were compatible with a lack of effect of iRGD treatment on the blood AFP levels in the three mouse models of liver fibrosis (Fig. 2a–c), suggesting that iRGD may not affect AFP levels in mice with fibrotic livers in the absence of HCC. Here, AFP is linked to hepatocellular carcinoma.